Fatal C difficile outbreaks add weight to HAI (healthcare associated infections) report
This article was originally published in Clinica
Executive Summary
An investigation into two serious outbreaks of Clostridium difficile at a single UK hospital, involving at least 33 deaths among 334 cases of infection, has pointed to "serious healthcare management failings". The report produced by the Healthcare Commission (CHAI) on the factors behind the outbreaks that occurred at the Stoke Mandeville Hospital (Buckinghamshire Hospitals NHS Trust), between October 2003 and June 2005, came as the Health Protection Agency reported a 17.2% rise in C diff infections in 2005, to almost 52,000 cases, fuelling the debate surrounding admission screening policy and related measures.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.